More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.93B
EPS
1.91
P/E ratio
11.6
Price to sales
0.99
Dividend yield
--
Beta
0.769537
Previous close
$22.11
Today's open
$22.13
Day's range
$21.78 - $22.51
52 week range
$11.84 - $24.99
show more
CEO
Mark S. Ordan
Employees
2150
Headquarters
Sunrise, FL
Exchange
New York Stock Exchange
Shares outstanding
85877386
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
4 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run. Stocks like KSS, HRTG, MD and NEM are seeing price strength, and the momentum is likely to continue.
Zacks Investment Research • Dec 5, 2025

Why Is Pediatrix Medical Group (MD) Up 11.1% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Dec 3, 2025

Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Nov 25, 2025

New Strong Buy Stocks for Nov. 24: SHIP, MD, and More
AS, ISRG, MD, SHIP and CIB have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 24, 2025.
Zacks Investment Research • Nov 24, 2025

Best Value Stocks to Buy for Nov. 24
JBSS, CIB and MD made it to the Zacks Rank #1 (Strong Buy) value stocks list on Nov. 24, 2025.
Zacks Investment Research • Nov 24, 2025

Best Momentum Stocks to Buy for Nov. 24
MD, LZB and CIB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Nov. 24, 2025.
Zacks Investment Research • Nov 24, 2025

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 21, 2025

Pediatrix Medical Q3 Earnings Beat Estimates on Declining Expenses
MD's Q3 profit tops on lower expenses and improved patient acuity, driving earnings past estimates despite softer revenues.
Zacks Investment Research • Nov 6, 2025

Pediatrix Medical Group, Inc. (MD) Q3 2025 Earnings Call Transcript
Pediatrix Medical Group, Inc. ( MD ) Q3 2025 Earnings Call November 3, 2025 9:00 AM EST Company Participants Mary Ann Moore - Chief Administrative Officer, Executive VP, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Kieran Ryan - Deutsche Bank AG, Research Division Jack Slevin - Jefferies LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Hello. My name is Dustin, and I will be your conference operator today.
Seeking Alpha • Nov 3, 2025

Pediatrix Medical Group Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results; Raises Full Year 2025 Adjusted EBITDA Outlook Range.
Business Wire • Nov 3, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Pediatrix Medical Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.